Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04590560
NA

What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer?

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

View on ClinicalTrials.gov

Summary

Italian, multicenter, study aimed at defining the best interval for screening women 45-49 and 70-74 years for Breast Cancer (BC). This research project includes (1) a controlled, prospective randomized non-inferiority trial to determine the optimal screening interval for women aged 45-49, with and without high mammographic density, (2) a retrospective data collection, with the same purpose, on screening performed by women aged 70-74, and (3) a qualitative research to define the best communication strategy.

Official title: What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer

Key Details

Gender

FEMALE

Age Range

45 Years - 49 Years

Study Type

INTERVENTIONAL

Enrollment

60000

Start Date

2020-02-06

Completion Date

2026-02

Last Updated

2024-12-09

Healthy Volunteers

No

Conditions

Interventions

DIAGNOSTIC_TEST

screening for breast cancer with tomosynthesis and synthetic 2D mammography performed at different interval compared to actual clinical practice

women will be screened for breast cancer using tomosynthesis and synthetic 2D mammography with an interval defined according to their randomization arm for a follow-up period of 6 years;

Locations (4)

Irst Irccs

Meldola (FC), FC, Italy

Istituto per lo studio, la prevenzione e la rete oncologica (ISPRO)

Florence, Italy

AUSL Romagna

Forlì, Italy

AOU Città della Salute e della Scienza

Torino, Italy